Emeritus full professor University of Antwerp Past Chairman dept of Cardiology Antwerp Univ Hospital Past EiC Eur Heart J Acute Cardiovasc Care
Antwerp, Belgium
Joined March 2010
- Tweets603
- Following377
- Followers733
- Likes937
Christiaan JM Vrints retweeted
Excited to see our new book, "Cardiovascular Pharmacotherapy: Evidence-Based Solutions for Clinical Practice", now published, co-edited with @DFCapodanno.
A big thank you to all the authors and contributors who made this project possible. shorturl.at/ypWu8
Christiaan JM Vrints retweeted
New state of the art review paper on the phenomenon of neoatherosclerosis after coronary stenting published.
#stent #DES #restenosis #neoatherosclerosis #cardiotwitter @ESC_Journals @escardio
Christiaan JM Vrints retweeted
Microvascular resistance reserve and cardiovascular outcomes: the FLOW-CMD registry : read more in EHJ.
doi.org/10.1093/eurheartj/eh…
#MicrovascularResistance #FLOWCMDRegistry #MicrovascularFunction #EHJ @escardio @ESC_Journals
Here's a link to a calculator to estimate RF-CL for patients with suspected CCS, as recommended by the 2024 ESC CCS Guidelines. It helps identify those with very low RF-CL for whom deferring further testing may be considered. rfcl-calculator.netlify.app
Nice viewpoint in EHJ: angina relief tracks the mechanism of ischemia. CFT-guided therapy beats unselected PCI. Diagnose the mechanism before treating! doi.org/10.1093/eurheartj/eh…
Heat Deaths in a ‘Cold’ Country (Belgium) Are a Warning to the Rest of Europe nytimes.com/2026/08/15/world… via @NYTimes
Christiaan JM Vrints retweeted
EuroIntervention ranks #1 in Interventional Cardiology with a CiteScore of 13.0
We are pleased to share that the journal has achieved outstanding results in the latest Scopus CiteScore 2025 rankings.
📈 CiteScore: 13.0
🥇 #1 in Interventional Cardiology
This reflects the scientific quality and impact of the work published in the journal, as well as the commitment of authors, reviewers, and the editorial team.
#CiteScore #InterventionalCardiology #Scopus
Christiaan JM Vrints retweeted
Coronary microvascular obstruction: the "no-reflow" problem that haunts STEMI care. New ESC clinical consensus on pathophysiology, prevention & management: a must-read. Read more in #EHJ.
doi.org/10.1093/eurheartj/eh…
#cardiotwitter @ESC_Journals @escardio
Christiaan JM Vrints retweeted
This state-of-the-art review provides a comprehensive overview of the pathophysiological mechanisms underlying the no-reflow/slow-flow phenomenon, covering invasive and non-invasive diagnostic tools, pharmacological and interventional treatment strategies, and the key clinical gaps that still need to be addressed in the field. eurointervention.pcronline.c…
Christiaan JM Vrints retweeted
Unique opportunity!
#CoronaryPhysiology
NO PRESSURE but…
Be O N E of the
F I R S T F I V E
to DM me:
get FREE REGISTRATION :
THE Physiology Course
18/05 Paris!
• UR an IC/fellow
• U want to master 🫀physiology
#ExceptionalOpportunity
#europcr2026
#LuckOfTheDraw
Another piece of evidence from ORBITA-2 supporting functional assessment before PCI, as recommended by the 2024 ESC CCS guidelines: Focal and Diffuse CAD Patterns and Placebo-Controlled Angina Relief With PCI 10.1016/j.jacc.2026.02.5126
Christiaan JM Vrints retweeted
The American Heart Association mourns the passing of the legendary cardiologist Eugene Braunwald, M.D., widely recognized as one of the most influential figures in the history of cardiovascular medicine. Over seven decades, his work reshaped the understanding and treatment of heart disease, leading many to call him the father of modern cardiology.
Braunwald was a lifelong contributor to the American Heart Association, helping advance its research and scientific mission, and was honored with some of the Association’s highest honors for his lasting influence on cardiovascular care and research. His influence extended well beyond his own discoveries, as generations of Association‑supported investigators, clinicians and academic leaders were trained by Braunwald or guided by the clinical trial standards and mentorship models he helped establish.
newsroom.heart.org/news/amer…
Mount Sinai registry: high prevalence of HIR criteria in PCI patients limits practical applicability, but IVUS improves outcomes. Best strategy 🤔— better PCI with IC imaging, or longer/more intense DAPT?eurointervention.pcronline.c…
Christiaan JM Vrints retweeted
You have a busy schedule?
Not being able to attend #ACVC26 ?
Don't worry, we got you covered.☑️
Listen to the wrap up of hot topics of this year congress selected beautifully by @ATycinska @JaninePoss @rafavidalperez
esc365.escardio.org/event/26…
#ACVCPodcast @escardio
Christiaan JM Vrints retweeted
The new issue is online, including:
• State-of-the-Art on antiplatelet pretreatment
• Prognostic impact of high ischaemic risk and complex PCI
• Updated coronary thrombectomy technique
and more
🔗eurointervention.pcronline.c…
#CardioTwitter #interventionalcardiology #cardiomed
@cvrints @g_giustinoMD @DLBHATTMD @Gurleen_Kaur96 @Drroxmehran @piccoloraf @espogiov @JuanFIglesias1
Christiaan JM Vrints retweeted
The perfect ending of an amazing day 1 at #ACVC26
🎯Recognition Awards go to @rafavidalperez Prof Josep Masip, Prof Marco Tubaro, Professor Hector Bueno and @JorgeNuche
🎯 #ACVC_ESC Lifetime Award goes to @thiele_holger
Moderated by @Sofiegevaert
@sighalvo
Congratulations to all🎉🎉🎉
@HannahSchaubro1
@sionis_a
@escardio @drmilicaa @franciscojlk
Christiaan JM Vrints retweeted
Outcomes of heart failure with reduced, mildly reduced, or preserved ejection fraction: the ESC HF III registry. Read more in EHJ.
ow.ly/Hl0v50Ynt58
#EHJ #cardiotwitter #heart #failure #preserved #ejection #fraction @ESC_journals @escardio
Christiaan JM Vrints retweeted
The clock is ticking - join as at #ACVC26
REGISTER HERE 👇
escardio.org/events/congress…
@escardio @ACVCPresident @drmilicaa @ESC_Journals @maria_bergami @FH_Verbrugge @franciscojlk @ehj_ed @rafavidalperez @sionis_a @HannahSchaubro1 @JasonKatzMD @seanvandiepen @cvrints
Christiaan JM Vrints retweeted
The SCAPIS study published in JAMA
~25,000 🇸🇪 participants, ~8 years follow-up. Adding coronary CT angiography #CCTA plaque information improved event prediction beyond clinical risk and calcium score.
This is the first study showing the added value of CCTA on top of the calcium score for risk prediction.
🎯 What to look for: lipidic soft (non-calcified) plaque.
👀 Practical takeaway: Consider a CT angiography for risk stratification on top of the calcium score.
Link: jamanetwork.com/journals/jam…
🎥 Posting my avatar summarizing the study.
Christiaan JM Vrints retweeted
Holiday season is at the end and do you know what comes next?
The first @escardio congress of the year #ACVC26
TOMORROW is the deadline for late breaking clinical trial submissions - if you have some raw research you still have time until noon CET
And don't forget to register for an early fee discount - 7 days left.
See you 🔜 in Lisbon. 🇵🇹 escardio.org/Congresses-Even…
